Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Advances in Clinical Neuroimaging

  • You have access
    Phase I safety and bioimaging trial of ifabotuzumab in patients with glioblastoma
    Hui Gan, Lawrence Cher, Po-Ling Inglis, Zarnie Lwin, Eddie Lau, Christian Wichmann, Uwe Ackermann, Alex McDonald, Ashray Gunjur, Nicole Coombs, Kirsten Remen, Nancy Guo, Sze-Ting Lee, Sylvia Gong, Jodie Palmer, Kunthi Pathmaraj, Graeme O'Keefe, Fiona Scott, Bryan Day, Andrew Boyd, Paul Thomas, Omar Ahmed, Dale Chappell, Cameron Durrant and Andrew Scott
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 104;
  • You have access
    Neuroinflammation in Semantic Variant Primary Progressive Aphasia
    Belen Pascual, Quentin Funk, Paolo Zanotti-Fregonara, Matthew Cykowski, Mattia Veronese, Elijah Rockers, Kathleen Bradbury, Meixiang Yu, Mohammad Nakawah, Gustavo Roman, Paul Schulz, Anithachristy Arumanayagam, David Beers, Alireza Faridar, Masahiro Fujita, Stanley Appel and Joseph Masdeu
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 101;
  • You have access
    11C-MC1 has adequate sensitivity to measure low density cyclooxygenase 2 (COX-2) in healthy human brain
    Xuefeng Yan, Andrea Zhang, Sami Zoghbi, Jeih-San Liow, Cheryl Morse, Maria Ferraris Araneta, Lester Manly, Maia Van Buskirk, Bruny Kenou, Sara Rubovits, William Miller, Victor Pike, Paolo Zanotti Fregonara and Robert Innis
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 103;
  • You have access
    Relationship between sigma-1 receptor availability and depressive or cognitive symptoms in acute early onset unipolar depression: a (S)-(-)-[18F]Fluspidine PET investigation
    Philipp Meyer, Maria Strauss, Georg Becker, Swen Hesse, Klara Bednasch, Barbara Ettrich, Franziska Zientek, Michael Rullmann, Julia Luthardt, Steffen Fischer, Marianne Patt, Barthel Henryk, Bernhard Wunsch, Peter Brust and Osama Sabri
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 106;
  • You have access
    Lipophilic Statins in Subjects with Early Mild Cognitive Impairment: Associations with Conversion to Dementia and Decline in Posterior Cingulate Brain Metabolism in a Long-term Prospective Longitudinal Multi-Center Study
    Prasanna Padmanabham, Stephen Liu and Daniel Silverman
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 102;
  • You have access
    Discordant low amyloid-β PET and high neocortical tau PET retention
    Natasha Krishnadas, Vincent Dore, Fiona Lamb, Regan Tyrrell, Svetlana Bozinovski, Victor Villemagne and Christopher Rowe
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 100;
  • You have access
    Initial Clinical Evaluation of [18F]DASA-23, a PET Imaging Tracer for Evaluation of Aberrantly Expressed Pyruvate Kinase M2 in Glioblastoma
    Corinne Beinat, Chirag Patel, Tom Haywood, Lewis Naya, Jessa Castillo, Bin Shen, Tarik Massoud, Andrei Iagaru, Guido Davidzon, Lawrence Recht and Sanjiv Gambhir
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 99;
  • You have access
    18F-MK6240 longitudinal tau PET in ageing and Alzheimer's disease
    Natasha Krishnadas, Vincent Dore, Rachel Mulligan, Regan Tyrrell, Svetlana Bozinovski, Kun Huang, Fiona Lamb, Samantha Burnham, Victor Villemagne and Christopher Rowe
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 105;
SNMMI

© 2025 SNMMI

Powered by HighWire